Cargando…
2-[(18)F]FDG PET in the Management of Radioiodine Refractory Differentiated Thyroid Cancer in the Era of Thyrosin-Kinases Inhibitors: A Real-Life Retrospective Study
Purpose To evaluate the role of 2-[(18)F]FDGPET/CT in the follow-up of radioiodine refractory thyroid cancer (RR-TC). Methods Forty-six 2-[(18)F]FDGPET/CT scans from 14 RR-TC patients were considered. Thyroid function tests: thyroglobulin (Tg), levothyroxine (LT4), and tyrosine-kinases inhibitors (T...
Autores principales: | Gay, Stefano, Raffa, Stefano, De’Luca di Pietralata, Anna, Bauckneht, Matteo, Vera, Lara, Miceli, Alberto, Albertelli, Manuela, Morbelli, Silvia, Giusti, Massimo, Ferone, Diego |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870858/ https://www.ncbi.nlm.nih.gov/pubmed/35204596 http://dx.doi.org/10.3390/diagnostics12020506 |
Ejemplares similares
-
Metabolic signature of hyposmia after mild COVID-19: An [18]F-FDG-pet study
por: Pardini, Matteo, et al.
Publicado: (2021) -
Positron Emission Tomography (PET) Imaging of Multiple Myeloma in a Post-Treatment Setting
por: Ferrarazzo, Giulia, et al.
Publicado: (2021) -
(18)F-FDG-PET/CT in Patients with Advanced, Radioiodine Refractory Thyroid Cancer Treated with Lenvatinib
por: Ahmaddy, Freba, et al.
Publicado: (2021) -
Positron Emission Tomography-Based Response to Target and Immunotherapies in Oncology
por: Donegani, Maria Isabella, et al.
Publicado: (2020) -
Beyond the Prognostic Value of 2-[(18)F]FDG PET/CT in Prostate Cancer: A Case Series and Literature Review Focusing on the Diagnostic Value and Impact on Patient Management
por: Borea, Roberto, et al.
Publicado: (2022)